Skip Navigation Links.
Activity Information
Introduction
Infection
Malignancy
Anemia
Vasculitis
Amyloidosis
Summary
References
Finish

Online CME Activity

RAPID: Long-term Management of Patients With Rheumatoid Arthritis—Part 1: Systemic Comorbidities

NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Title:
RAPID: Long-term Management of Patients With Rheumatoid Arthritis—Part 1: Systemic Comorbidities
Release Date:
10/15/2008
Expiration Date:
10/15/2010
Topics:
Chronic Pain, Rheumatoid Arthritis, Rheumatology
Primary Audience:
Primary Care
Activity Format:
Clinical Review
Credits:
2.00 AMA PRA Category 1 Credits™, 2.00 AANP, 2.00 ANCC

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Empty Star 82%

Learning Objectives

Explain the role of the primary care physician in the ongoing management of patients with rheumatoid arthritis

Describe the health risks of disease-modifying antirheumatic drug therapy, including infections and malignancies

Accreditation

This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
2.00 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
2.00 AANP Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 2 contact hours of continuing education, which includes 1.0 hours of pharmacology.
2.00 ANCC Pri-Med Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity for 2 contact hours is provided by Pri-Med Institute.
View Additional Accreditation Information

Faculty and Editorial Board

Written By: Joan M. Von Feldt, MD, Associate Professor of Medicine, University of Pennsylvania, Division of Rheumatology, Philadelphia, PA

Edited By: Mary Fitzgerald, MS, RN, Pri-Med Institute

Financial Disclosure Statement(s)

Dr Von Feldt has no financial relationships to disclose.

Ms Fitzgerald has no financial relationships to disclose.

The content collaborators at The Chatham Institute have no financial relationships to disclose.

Education Partner:

The Chatham Institute

Commercial Support:

Abbott Laboratories, Amgen Inc./Wyeth Pharmaceuticals, Bristol-Myers Squibb, Centocor, Inc., Genentech and Biogen Idec.

Instructions for Obtaining Credit:

Complete this activity. Answer the questions in the attached posttest and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.

Computer System Requirements:

Internet Explorer (version 5.5 and above) is the recommended browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A minimum screen resolution setting of 800 x 600 is recommended. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.